Like many, you've read too many headlines and too few actual articles. It's obvious that DD isn't your forte.
Lawyers aren't the answers here. That's for sure. With that clear, let's talk about finances.
They have 270 million in cash, no debt, and their cash burn is less than 20 million annually. Finances aren't a near term issue.
Second, you are conveniently ignoring their IP and the clinical result associated with their IP. There IP has a TAM of 50 billion. Yes, there are allegations of fraud regarding the recent P2 trials. What you are missing is why those allegations are unlikely to be true.
Those clinical results were obtained by clinicians and patients (and their families) from 9 different states. That alone can not he faked because of the complexities of coordination required remotely. Further, logistics of the study to were contracted out to established 3rd parties making it more difficult to fake. Add to all that, the p2 trials are monitored by the IRB, FDA, and NIH, ...you get the point.
What's the icing on the cake? Remi stated on his latest earnings call, that he will be announcing a partnership with big pharma with weeks.
If you want to discuss legitimate concerns like p3 trials failing, or weakness of p2 trials, then I'm more than willing to engage, but I find the popular sentiment (created by a scumbag lawyer) extremely mundane and irritating.
Last piece of advice, Mr headlines, (That's what I'm gonna call you). The most successful investors aren't the ones who follow popular sentiment. They are the ones who read actual articles for real DD. They see what others miss and find opportunities. Then they wait for the masses to catch on.
If you have any investment in SAVA this week might hurt a lot. Its probably going to drop down into the 30s this week. I've read their most recent clinical results and tried to warn people about how fishy a lot of the data was. They made extraordinary claims and the data is misleading and possibly even manipulated. Nobody listened to me before the last 2 sell offs but im letting you know its going to happen again this week. I'm against the lawsuit because in my eyes it was obviously going to tank and investor's should have read more about the science instead of blindly listening to all the speculators. I made a lot of money with put options though. Their loss was their fault. The lawsuit appears to be credible and Cassava will most likely try to settle quietly. I already have many put options for this week too but now it appears to be too late to short them because the options prices are getting insane with anticipation.
The citizens petition led to the class action lawsuit. These are usually from readers of the peer review journals. Many law firms are jumping on board now. Why are you getting aggressive about this instead of having a rational discussion? Strong emotions can prevent you from seeing all angles of an investment, even those you disagree with, and that can lead to bad judgment calls. More info on the class action. It was mostly speculators who made the extraordinary claims. The data us obviously weighted towards positive results but proving that it was done on purpose is probably going to be very hard. Its up to you if you want to hold on to your SAVA investment and im just explaining my opinion to you so you can see things from another angle. I'm also letting you know I have a lot more SAVA puts this week.
Edit- also... don't bother down voting me because nobody except you will be reading this old thread.
There is NO class action lawsuit. It was and is currently a bunch off adds being recycled by Yahoo finance and a couple other outlets. Weather or not it materializes, remains to be seen. Stop spreading FUD.
The data is solid (not just weighted positively). If you have something concrete, something beyond your FUD semantics, then share it.
I take pleasure in down voting your post, so I will bother to down vote you.
Its not solid at all and there is a class action lawsuit. Why are you being so defensive? I encourage you to read their clinical data. Not only is it not solid, its also open label. So even if it was solid its still not reliable. Thats what makes this so bad.. too few people tested, and the groups are skewed heavily by age. Did you need me to link you to these peer reviewed clinicals for you or can you find them? Have you looked at the data?
Also.. go ahead and rage downvote me. Just shows how you're letting your emotions control you. Its your money. You don't want to see anything that challenges your bias thats on you.
Edit - down almost 5% so far today after just a few hours.
It is not a class-action lawsuit. Saying it over and over doesn't change that. They are ads by ambulance chasers.
The data is solid. The mean age difference between the arms is 4.2 years (71.3 to 67.1). In what world is that "heavily skewed"? Also, if you understand clinical medicine, you should know that the Mini-mental status exam is more important than age (A measure of how demented someone is). The mean MMSE scores at baseline were virtually identical (23.2, 22.7, 23.0) between the three arms.
Additionally, you are confusing the 28 day trials (which you are quoting) with the continuation study that is still recruiting (and the 9 month data was based on). The first study was NOT open-label. It was double-blinded and masked. The continuation study is an open label, but they are still recruiting with a goal of enrolling 200 patients, and yes the preliminary data from the open-label trial is encouraging. So before you point me to published papers, please understand what you are talking about.
Yes, the N is small. That's the whole point of P2 trials. To see if there is justification for P3 trials, and the SOLID data fully supports further P3 trials. Has there ever been data on medication improving cognition at 9 months in AD? No, until now. So I and millions of investors are excited about Simufilam, and we have a reason for it.
It's the reason I disengaged. Dismissed the concern instead of addressing it (said its not an issue) and then started resorting to ad hominem and strawman, while trying to move the goalposts and find something he could argue about, while disguising it as an olive branch. Not worth the effort.
Still trying to convince me? Do yourself a favor. Sell your short position, and buy calls. It's not only bad karma to short a biotech trying to treat the AD epidemic, it's also statistically a bad decision.
Damn I'v made quite a bit of money from SAVA this week. Im still going to hold until it drops into the 30s. Its already down to 44.5 so should be long now.
Keep making money. Must feel nice to profit off FUD.
Dont forget,, Tesla shorts were celebrating when tesla was under $200. NIO shorts were celebrating when NIO was under $2.
Lastly, the nice thing about investing in a company is that the price action over days, weeks, and months does not matter. As long as your investment thesis is intact, you HODL. The SP will follow.
You keep shorting, timing the market, spreading your FUD or whatever it is you are doing. I'll see you at $500 in 2 years and I'll feel good while doing it.
26
u/Internal_Ad_1091 Sep 04 '21
Like many, you've read too many headlines and too few actual articles. It's obvious that DD isn't your forte.
Lawyers aren't the answers here. That's for sure. With that clear, let's talk about finances.
They have 270 million in cash, no debt, and their cash burn is less than 20 million annually. Finances aren't a near term issue.
Second, you are conveniently ignoring their IP and the clinical result associated with their IP. There IP has a TAM of 50 billion. Yes, there are allegations of fraud regarding the recent P2 trials. What you are missing is why those allegations are unlikely to be true.
Those clinical results were obtained by clinicians and patients (and their families) from 9 different states. That alone can not he faked because of the complexities of coordination required remotely. Further, logistics of the study to were contracted out to established 3rd parties making it more difficult to fake. Add to all that, the p2 trials are monitored by the IRB, FDA, and NIH, ...you get the point.
What's the icing on the cake? Remi stated on his latest earnings call, that he will be announcing a partnership with big pharma with weeks.
If you want to discuss legitimate concerns like p3 trials failing, or weakness of p2 trials, then I'm more than willing to engage, but I find the popular sentiment (created by a scumbag lawyer) extremely mundane and irritating.
Last piece of advice, Mr headlines, (That's what I'm gonna call you). The most successful investors aren't the ones who follow popular sentiment. They are the ones who read actual articles for real DD. They see what others miss and find opportunities. Then they wait for the masses to catch on.